Company news

Recently, our company (Jiaxing Cytowiz Incorporated Co.,Ltd and Jiangxi Cytowiz Incorporated Co.,Ltd) has undergone strict review by SGS international authoritative testing and certification institutions, successfully passed the ISO13485:2016 international quality management system certification audit, and obtained the certificate.

The successful passing of this certification is an effective verification that our quality management system has reached the international level, laying a solid foundation for our company's products to enter a larger and broader market; At the same time, it is also a manifestation of the company's consistent pursuit of quality and creating value for customers. The company will continuously strengthen the construction of its quality management system and continue to research and develop first-class "crystal" products.

Jiaxing Cytowiz Incorporated Co.,Ltd has obtained the Medical Device Quality Management System Certification issued by SGS, covering the research and production of fully automated liquid based cell processing systems and reagents for pathological sample processing.

Jiangxi Cytowiz Incorporated Co.,Ltd has obtained the Medical Device Quality Management System Certification issued by SGS, covering the research and production of fully automated liquid based cell processing systems, cervical cytology scanning image analysis systems, and reagents for pathological sample processing.

ISO 13485 Medical Device Quality Certification is an international certification specifically designed for the international quality management standards of the medical device industry. This certification standard requires enterprises to meet high-quality requirements in all aspects of design, development, production, sales, and after-sales service, and to manage and supervise the entire lifecycle of medical devices to ensure product quality, safety, and effectiveness.

The acquisition of ISO13485 system certification this time will bring many benefits to the crystal casting team, including but not limited to:

☑Improve and enhance the management level of crystal casting, and avoid legal risks;

☑Enhance the quality and competitiveness of crystal casting products, and increase their market share;

☑ Enhance market competitiveness and enhance customer recognition;

☑Through effective risk management, effectively reduce the risk of product quality accidents and adverse events, and avoid violations;

☑Provide a passport for Jingzhu Biotechnology to explore the international market.

The high-quality and fully automated cervical cytology screening products developed and produced by Jingzhu Biotechnology mainly include JZ SP-6000, JZ SP-2400, and JZ SCANNER 1650.

In terms of product application, the crystal casting bio liquid based cell slicing, staining, and sealing integrated machine has been widely used in cervical cancer detection across the country. Long term and extensive application results have shown that crystal casting products have excellent efficiency and applicability in the one-stop assembly line of cell slicing, staining, sealing, and scanning.

The company will continue to adhere to the high-quality development strategy in the future, providing cost-effective products for fields and customers with special requirements for high-quality products. Taking the acquisition of the ISO 13485:2016 medical standard system as an opportunity, the company will implement standard requirements, effectively manage risks, enhance technical strength, improve quality control system, and better provide professional and reassuring product services for medical equipment customers.